In Vitro Fertilization Market (By Instrument: Equipment, Disposable Devices, Culture Media; By Procedure Type: Fresh Nondonor, Frozen Nondonor; By Providers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global in vitro fertilization market size was estimated at around USD 25.34 billion in 2023 and it is projected to hit around USD 43.57 billion by 2033, growing at a CAGR of 5.57% from 2024 to 2033.

Key Pointers

• Europe region led the market with the largest market share of 37% in 2023.
• By Instrument, the culture media segment held the largest revenue share of 41% in 2023.
• By Instrument, the disposable devices segment is projected to exhibit the fastest growth rate from 2024 to 2033.
• By Procedure Type, the frozen non-donor segment registered the maximum market share in 2023.
• By Providers, the fertility clinics segment had the largest market share in 2023.

In Vitro Fertilization Market Overview

In vitro fertilization (IVF) stands as a groundbreaking technique within the reproductive medicine, offering hope to couples facing infertility issues. The IVF market encompasses a diverse range of technologies, procedures, and services aimed at assisting individuals and couples in achieving successful pregnancies. As advancements in medical science continue to evolve, the IVF market has witnessed significant growth, driven by factors such as increasing infertility rates, advancements in assisted reproductive technologies (ART), and growing awareness and acceptance of IVF procedures.

In Vitro Fertilization Market Growth Factors

The growth of the in vitro fertilization (IVF) market is driven by an advancement in assisted reproductive technologies (ART) have significantly improved success rates, making IVF a more viable option for couples struggling with infertility. Additionally, the increasing prevalence of infertility due to factors like delayed childbearing and lifestyle changes has driven demand for IVF services. Furthermore, expanding access to IVF treatments through improved healthcare infrastructure and insurance coverage has widened the market reach. The growing acceptance of third-party reproduction options, such as donor eggs and gestational surrogacy, has also contributed to market expansion. Overall, these factors combined underscore the sustained growth and evolution of the IVF market, promising continued advancements in reproductive medicine and increased accessibility to fertility treatments for individuals and couples worldwide.

In Vitro Fertilization Market Trends:

• Rising Demand for Genetic Testing: Increased awareness and acceptance of genetic testing techniques, such as comprehensive chromosomal screening (CCS) and preimplantation genetic diagnosis (PGD), are driving demand for IVF procedures with a focus on selecting genetically healthy embryos.
• Expansion of LGBTQ+ Family Building: The LGBTQ+ community's growing interest in family building through assisted reproductive technologies, including IVF and surrogacy, is fueling market growth and prompting clinics to offer inclusive services tailored to diverse family structures.
• Emergence of Low-Cost IVF Clinics: The proliferation of low-cost IVF clinics and alternative pricing models is making IVF more accessible to a broader segment of the population, driving competition and potentially reducing treatment costs.
• Telemedicine and Remote Monitoring: The integration of telemedicine platforms and remote monitoring technologies into IVF services allows for greater convenience, flexibility, and patient engagement throughout the treatment process, particularly in light of the COVID-19 pandemic.
• Focus on Patient-Centric Care: IVF clinics are increasingly prioritizing patient experience and satisfaction by offering personalized treatment plans, comprehensive support services, and transparent communication to ensure a positive journey through fertility treatment.

Instrument Insights

The culture media segment held the highest market share, accounting for 41% of total revenue in 2023. This dominance is attributed to factors such as increased research efforts and the availability of funding aimed at enhancing culture media quality. In July 2022, FUJIFILM Irvine Scientific introduced Heavy Oil for Embryo Culture, a sterile mineral oil designed specifically for IVF procedures. This product addresses key concerns including pH balance, osmolality changes, and media preservation, thanks to its optimal viscosity.

The disposable devices segment is projected to exhibit the fastest growth rate during the forecast period. This growth is driven by industry players introducing disposable devices such as slides, needles, and chambers to ensure compliance with sterility and regulatory standards. These advancements are anticipated to boost the adoption of disposable IVF devices. Recent market innovations include disposable slides for sperm counting, imaging-based systems for isolating the best motile sperm, and the utilization of disposable microchips.

Procedure Type Insights

The frozen non-donor segment emerged as the dominant force in the market, capturing the largest revenue share in 2023, and is projected to experience the swiftest growth throughout the forecast period. This dominance can be attributed to factors such as its cost-effectiveness compared to fresh non-donor cycles and the less invasive nature of the procedure. Conversely, the fresh donor segment is expected to witness significant growth in the coming years. According to the 2020 National ART Summary report, approximately 1,477 ART cycles utilized fresh donors, with approximately 53.9% of transfers resulting in live-birth deliveries in the U.S.

While some centers offer risk-sharing plans and refunds for a limited number of cycles, the Advanced Fertility Center of Chicago stands out with its IVF reimbursement plan, providing a 100% refund for up to four cycles involving fresh embryos. There is a growing concern regarding sperm donation due to the lack of screening before donation, particularly as the Human Fertilization and Embryology Act 1990 does not cover fresh sperm donation. Consequently, there has been a revision of guidelines by HEFA, mandating a 180-day quarantine period for fresh sperm to undergo HIV screening. Additionally, NHS funding for fertility treatment using donated gametes is limited for homosexuals and single parents.

Providers Insights

The fertility clinics segment emerged as the market leader, capturing the largest revenue share in 2023, and is projected to experience the fastest growth over the forecast period. This dominance is attributed to the increasing demand for assisted reproductive technology (ART) treatments, resulting in a notable rise in the number of fertility clinics and ART centers. Factors such as cost-effectiveness, the availability of specialist expertise, and the minimal risk of Hospital-Acquired Infections (HAIs) are expected to propel the growth of the fertility clinics segment. It's worth noting that IVF treatments are also conducted within hospital settings.

The hospitals and other settings segment are anticipated to witness significant growth at a considerable compound annual growth rate (CAGR) throughout the forecast period. Many multispecialty hospitals offer infertility treatments, including In-vitro Fertilization (IVF). The increased accessibility and availability of these treatments have led to a growing preference for hospitals for infertility care. However, it's important to acknowledge that IVF treatments in hospitals typically incur higher costs compared to those in fertility clinics. This is primarily due to the necessity for highly skilled physicians and staff to perform these complex procedures. Consequently, the employment, remuneration, and training costs associated with maintaining a dedicated IVF staff in hospitals are considered less favorable. These costs are particularly pronounced in developed countries such as the U.S. and UK.

Regional Insights

Europe emerged as the dominant force in the market, capturing the largest revenue share of 37% in 2023. This can be attributed to several factors, including a significant rise in medical tourism, particularly with an increasing number of Americans opting to travel to the Czech Republic for more cost-effective IVF treatments. Additionally, individuals unable to afford overseas travel are now seeking IVF treatments within the United States at approximately one-third of the cost charged by domestic clinics. In July 2022, Fairtility received approval from the European Union to utilize artificial intelligence (AI) for embryo assessment. The EU's new medical device regulation standards have facilitated the development of a commercially available AI tool, which holds the potential to enhance the success rate of IVF procedures.

North America is also poised to experience a surge in demand for fertility treatment in the coming years. Lifestyle changes, including inadequate nutrition, heightened stress levels, increased obesity rates, unhealthy dietary habits, escalating pollution levels, lack of physical activity, and the prevalence of medical conditions such as diabetes, have contributed to a higher incidence of infertility in the region. The growth in North America's fertility market can be attributed to various factors, including the standardization of procedures through regulatory reforms, increased automation, government funding for egg and sperm storage, and the introduction of additional IVF treatments by industry players.

In Vitro Fertilization Market Key Companies

• AmbroiseParé Group
• Amedes MVZ Cologne GmbH
• AMP Center St Roch
• AVA Clinic Scanfert
• Bangkok IVF center
• Betamedics
• Biofertility Center
• Bloom Fertility and Healthcare
• Bloom Fertility Center
• Bourn Hall Fertility Center

In Vitro Fertilization Market Segmentations:

By Instrument

• Disposable Devices
• Culture Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other

By Procedure Type

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

By Providers

• Fertility Clinics
• Hospitals & Others Setting

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)